Dexter I totally agree. I am a medic but the immunology area is very complex and very specialised. I believe WP is not relaxed in this area as it is not like the two other divisions where he is at home with the sales team and their promotions etc. These are more akin to where he came from with big pharma.I have suggested that we will have some movement on the divestment of the immunology within two months as WP will act to get the momentum going and achieving a CF positive goal. I hope I my guess is correct as the situation is a little painful and is not reflective of a dynamic management.
"Take a Closer Look", page-838
-
- There are more pages in this discussion • 390 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |